Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans

NCT03601624 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma in Relapse
Multiple Myeloma Progression
Refractory Multiple Myeloma

Interventions

DRUG: Pomalidomide

Sponsor

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado